DOCS 📈 Doximity - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US26622P1075
DOCS: Digital, Tools, Platform, Collaboration, Networking, Documentation
Doximity Inc, listed on the New York Stock Exchange as DOCS, operates a comprehensive cloud-based digital platform designed specifically for medical professionals across the United States. This platform offers a suite of digital tools tailored to the needs of the medical community, facilitating collaboration among colleagues, access to the latest medical research and news, and efficient management of professional careers and schedules. Additionally, it streamlines administrative tasks such as documentation and paperwork, and enables the conduct of virtual patient visits, thereby enhancing the overall efficiency and reach of medical practice. The platform's primary user base includes physicians, nurse practitioners, physician assistants, and medical students, as well as pharmaceutical manufacturers and healthcare systems, indicating its broad applicability and utility within the healthcare sector.
The company's history traces back to its incorporation in 2010, initially known as 3MD Communications, Inc., before adopting the name Doximity Inc. in June of the same year. Headquartered in San Francisco, California, Doximity has established itself as a significant player in the health care technology sub-industry. With its web presence at https://www.doximity.com, the company provides easy access to its services and information for its members and the public alike. As a publicly traded company with the ISIN US26622P1075, offering common stock, Doximity Inc. is categorized under the GICS Sub Industry of Health Care Technology, reflecting its core business and operational focus.
By leveraging cloud-based technology, Doximity Inc. aims to address the complex needs of medical professionals, from networking and professional development to the management of day-to-day clinical and administrative tasks. The platform's emphasis on facilitating virtual patient visits underscores its commitment to adapting to the evolving landscape of healthcare delivery, where remote and digital services are becoming increasingly integral. Through its services, Doximity Inc. seeks to support the efficiency, effectiveness, and connectivity of the medical community, ultimately contributing to improved patient care and outcomes.
Additional Sources for DOCS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DOCS Stock Overview
Market Cap in USD | 10,367m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception | 2021-06-24 |
DOCS Stock Ratings
Growth 5y | 1.43% |
Fundamental | 89.2% |
Dividend | - |
Rel. Strength Industry | 2089 |
Analysts | 3.56/5 |
Fair Price Momentum | 59.30 USD |
Fair Price DCF | 31.43 USD |
DOCS Dividends
No Dividends PaidDOCS Growth Ratios
Growth Correlation 3m | 70.9% |
Growth Correlation 12m | 68% |
Growth Correlation 5y | -56.1% |
CAGR 5y | 2.52% |
CAGR/Mean DD 5y | 0.04 |
Sharpe Ratio 12m | 1.34 |
Alpha | 65.40 |
Beta | 1.73 |
Volatility | 41.38% |
Current Volume | 7962.5k |
Average Volume 20d | 2133.4k |
As of December 21, 2024, the stock is trading at USD 57.83 with a total of 7,962,519 shares traded.
Over the past week, the price has changed by +10.91%, over one month by +15.89%, over three months by +41.46% and over the past year by +112.61%.
Yes, based on ValueRay Fundamental Analyses, Doximity (NYSE:DOCS) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 89.22 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOCS as of December 2024 is 59.30. This means that DOCS is currently overvalued and has a potential downside of 2.54%.
Doximity has received a consensus analysts rating of 3.56. Therefor, it is recommend to hold DOCS.
- Strong Buy: 4
- Buy: 2
- Hold: 12
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, DOCS Doximity will be worth about 67.5 in December 2025. The stock is currently trading at 57.83. This means that the stock has a potential upside of +16.76%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 55.3 | -4.5% |
Analysts Target Price | 26.3 | -54.5% |
ValueRay Target Price | 67.5 | 16.8% |